Beijing To Offer Free Anti-TB Drugs, Exams To Migrants
This article was originally published in PharmAsia News
Executive Summary
The Chinese capital of Beijing has decided to offer the same free access to anti-tuberculosis drugs for migrants as it does for Beijing citizens. The deputy director of the Beijing Municipal Health Bureau said the free drugs would be provided in addition to free exams for the disease. The official cited a TB increase among migrants and an increase in cases of drug-resistant versions of the disease. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.